An interventional study of Diabetes Self-Management Program (DSMP) and Tailored Patient Navigation (PN) only in Diabetes Mellitus, sponsored by Nancy Schoenberg. Completed at 1 site in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2024-08-29.
Sponsored by Nancy Schoenberg · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 3,023 studies in Diabetes Mellitus with a site in United States — 289 open to participants now, 388 under way, 12 of them phase 3. Diabetes Mellitus · United States.
Among the 3,023 studies in Diabetes Mellitus with a site in United States, this one is the 238th largest by enrollment of the 2,502 interventional ones that give a count, is one of 115 that started in 2018, is one of 1,418 with no phase, and was the 2,091st registered.
8,295 studies on the registry are indexed under Diabetes Mellitus; 1,071 are open to participants now.
Browse Diabetes Mellitus studies →289 of the 3,023 studies in Diabetes Mellitus with a site in United States are open now. Recruiting first, the newest first:
Bettina Mittendorfer · Sites in United States
Ages 18–100 · Healthy volunteers
University of California, Los Angeles · Sites in United States
Ages 18+
Wayne State University · Sites in United States
Ages 16–20
Mayo Clinic · Sites in United States
Ages 18+
Montefiore Medical Center · Sites in United States
Ages 18–85
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 649 Diabetes Mellitus studies recruiting now, 358 (55%) set no upper age limit and 194 (30%) stop at 75 or younger; 89 take children under 18; 181 take healthy volunteers.
This study: 18 Years to 99 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
3,023 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 262 · Phase 2 371 · Phase 3 340 · Phase 4 215
First in 1976; this study’s year is marked. 115 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 701 is above the median of 80 across 6,027 interventional studies indexed under Diabetes Mellitus.
Median enrollment 82 across the 2,502 interventional studies, 159 across the 499 observational. Of the 2,399 that completed or were terminated, 991 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
852 of 3,023 have an industry lead sponsor. The 10 most frequent:
Nancy Schoenberg is the lead sponsor of 5 studies on the registry; 1 is open to participants now.
Nancy Schoenberg has 1 study filed under Diabetes Mellitus — fewer than ten, so there is no comparison to draw.
139 of the studies in Diabetes Mellitus with a site in United States that are under way reach primary completion within a year, 4 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03982693Phase 3Mt. Sinai Medical Center, MiamiTrial to Assess Chelation Therapy in Critical Limb Ischemia | 2026-12 |
| NCT05174052Phase 3University of OklahomaDapagliflozin in Patients With Atrial Fibrillation (DAPA-AF) | 2027-04 |
| NCT02262832Phase 3National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy | 2027-07-31 |
| NCT07400653Phase 3PfizerA Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) | 2027-10-12 |
| NCT07556354University of Alabama at BirminghamEmpowering Faith-based Communities to Provide Personalized Diabetes Self-management Education and Support (DSMES) in the Magic City | 2026-11 |
Add all 139 to your calendar (.ics) → With an account.
Among the 3,023 studies in Diabetes Mellitus with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Background and justification: Nearly 29 million Americans (9.3% of the population) have type 2 Diabetes Mellitus (T2DM) and another 86 million are considered prediabetic, 20-30% of whom will develop diabetes within five years.4,5 T2DM disproportionately affects those from lower socioeconomic status (SES) and rural backgrounds. Appalachian residents represent an extreme version of this already vulnerable population, with rates of diabetes 46% higher than national averages.6,7 The investigators have developed, pilot tested (N=41) and refined (N=48 in-depth interviews, 4 focus groups with 31 participants, and 2 CAB meetings with 16 members), a culturally appropriate, feasible, and promising intervention that combines diabetes self-management education and tailored patient navigation intervention., Goal: Our goal focuses on reducing HbA1c, BMI, blood pressure, lipids, and waist circumference and improving T2DM self-management and clinic attendance. Leveraging local assets, including faith communities, local health facilities, trained community health workers, and social support, the investigators will expand a promising and refined pilot study and assess outcomes, satisfaction and cost effectiveness. Innovation and impact: The proposed project is among the first RCT to combine the two most influential approaches to diabetes control-- self-management education and tailored patient navigation in a community setting. The Community to Clinic Navigation (CCN) intervention has the potential to sustainably empower hard to reach populations with effective self-management education and enhance the quality of healthcare in traditionally underserved communities, greatly improving T2DM outcomes.
Background: Appalachian residents maintain disproportionately high rates of Type 2 Diabetes Mellitus (T2DM) and suffer tremendous burdens from diabetic complications. The main challenges to stemming adverse outcomes from T2DM involve ensuring optimal clinical care and self-management. Because the prevalence of diabetes has tripled since 2005, the already low supply of primary care physicians combined with this tremendous chronic disease burden places huge demands on providers in rural Appalachia. Enhancing the quality and efficiency of these practices by linking to community health workers has the potential of mitigating the adverse effects of these shortages.
Patient navigation, particularly a clinic to community navigation (CCN) model offers an innovative approach to address these inequities. Patient navigation has been implemented almost exclusively in the cancer setting, despite being promising for chronic disease management. The proposed project is, to our knowledge, the first to test a hybrid model of clinic (health promotion professional) plus community (community health worker) navigation among rural residents. Clinical patient navigation has been shown to facilitate appointment setting and return visits, may improve goal setting, and enhances some adherence (medication taking, blood glucose testing), but does not address some key psychosocial (self-efficacy, patient activation) and practical concerns (transportation, childcare, self-management) challenges. Community-based navigation programs have been shown to enhance self-efficacy, decrease community barriers to care (e.g., transportation), and improved self-management, but may be less effective in ensuring return visits and working collaboratively with the doctor.
Research Procedures: The consort diagram (Figure 1) below provides an estimation and visual description of the recruitment and sampling frame.
Fig 1: Consort diagram of enrollment
There will be three arms. For those randomized to the diabetes self management program (n=435), within two weeks of initial recruitment and baseline assessment, project staff will schedule the participant to attend a group Diabetes Self-management Program, a six week, lay lead and en evidence-based diabetes home self-management program (See Table 1, DSMP contents). Staff will arrange for the group sessions of the DSMP. One session will take place every other week. Upon completion of the DSMP program, approximately three month later, clinic navigation will be implemented. For those randomized to the Patient Navigation group, within two weeks of initial recruitment and baseline assessment, project staff will schedule the participant to meet with the Community Health Worker who will strategize about insuring that patients make their doctors' appointments as scheduled. The CHW/Patient Navigator will make at least 4 calls to each participant randomized to this group. For those randomized to the combined Community to Clinic Navigation, CCN (n=435), both of the activities for the Diabetes self management education group and the Patient navigation will be conducted. At month 5-6, the posttest will take place. To assess sustainability, 3-4 months later, navigation again will take place. An interviewer will complete the exit interview in month 10-11 using the same assessments. All throughout the intervention, standard medical visits will take place.
Fig 2: Flow diagram of intervention and control activities by month
Table 1: DSMP contents and conduct:
Class Number Content/Objectives./Activities
Table 2: Timeline
Activity Q1 Q2 Q3 Q4 Staff training Recruitment, informed consent, enrollment, randomization Baseline medical record review/ interview 0 CCN arm participants receive DSM sessions (6 sessions total) and navigation to clinic X X Posttest 1 0 CCN arm Navigation X Exit interview 0 CCN= clinic to community navigation (intervention arm); DSM= diabetes self-management; X= intervention activity; 0= assessment
Table 3: Variables Data sources and collector Main outcomes HbA1C, blood pressure, lipids, waist circumference, BMI Additional outcomes: Self-management outcomes Medication taking, blood glucose testing, appointment adherence, diet, physical activity, foot and eye care.
Assessments by UK project staff Diabetes Empowerment Scale (self-efficacy), patient activation Assessments by UK project staff Sociodemographic, self-perceived health status, depression, Clinic attendance, assessments by UK project staff
Two main revisions for this trial were implemented.
Data collection for several secondary outcomes:
Several significant events undermined the original data collection plan including:
Exclusion Criteria:
-
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
group education classes of the Diabetes Self-Management Program, (DSMP)
Behavioral: Diabetes Self-Management Program (DSMP)
assisting patients in navigation to physician offices, allowing for standard of care to follow.
Behavioral: Tailored Patient Navigation (PN) only
Both group education classes and patient navigation
Behavioral: DSMP AND Tailored Patient Navigation
group education classes of the Diabetes Self-Management Program, (DSMP)
Behavioral: Diabetes Self-Management Program (DSMP) Delayed
The the Diabetes Self Management Program (DSMP) in a group setting: participants will attend a six week, evidence-based diabetes home self-management program. The goal of this arm of the project is to try to get participants to engage in better diabetes self-care (blood glucose testing, medication taking, diet, exercise, stress reduction, etc.). Participants will complete biometric data and surveys at 3, 6, and 9 months post randomization.
Tailored Patient Navigation (PN) only: trained Community Health Workers (CHW) will meet one-on-one with participants to assess the barriers experienced in adhering to medical appointments and will implement a navigation program accordingly. The goal of this arm of the project is to try to get participants to attend recommended medical appointments. PN has been shown to improve health behavior and increase self-efficacy, all with low costs.
DSMP AND Tailored Patient Navigation : patient navigation followed by 6 weeks of DSMP classes after the 3 month post-test interview.
Also known as: Clinic to Community Navigation (CCN)
Groups randomized to DSMP Delayed will receive 6 weeks of DSMP classes after the 3 month post-test interview. Participants will complete biometric data and surveys at 3, 6, and 9 months post randomization.
Change in Hemoglobin A1c
Changes in hemoglobin A1c (HbA1c) will be measured with a Bayer DCA 2000+ Analyzer (21), which has a test coefficient of variation \< 5% consistent with requirements of the National Diabetes Data Group.
Time frame: Baseline, month 3, month 6, month 9
Change in Body Mass Index
Change in calculated as a change in weight in kilograms divided by the square of height in meter.
Time frame: Baseline, month 3, month 6, month 9
Change in Waist Circumference
Change in Waist circumference at the umbilical waist using the Tech-Med model cat. no. 4414.
Time frame: Baseline, month 3, month 6, month 9
Number of Participants Attending a Clinic Visit
Number of participants with a primary care provider that attended a clinic visit with that provider within the last 3 months.
Time frame: Baseline
Change in Systolic Blood Pressure
Change in systolic blood pressure will be reported as the average of two sphygmomanometer readings
Time frame: Baseline, month 3, month 6, month 9
Change in Diastolic Blood Pressure
Change in diastolic blood pressure will be reported as the average of two sphygmomanometer readings
Time frame: Baseline, month 3, month 6, month 9
High Density Lipoprotein (HDL)
blood will be drawn and HDL will be measured using a Cholestech LDX point of care machine. Data will be reported as the change in HDL over 18 months
Time frame: Baseline to month 9
Low Density Lipoprotein (LDL)
blood will be drawn and LDL will be measured using a Cholestech LDX point of care machine. Data will be reported as the change in LDL over 18 months
Time frame: Baseline to month 9
Total Cholesterol
blood will be drawn and Total cholesterol will be measured using a Cholestech LDX point of care machine. Data will be reported as the change in total cholesterol over 18 months
Time frame: Baseline to month 9
Change in Physical Component Summary Score of SF-36
The RAND SF-36 physical component summary (PCS) score is a domain summary score that is part of the 36-Item Short Form Health Survey (SF-36). Scores range from 0 - 100. Higher scores indicate better health or function. The PCS score is calculated by adding up standardized, weighted scores based on eight domains of health, including physical functioning and pain: Limitations in physical activities due to health problems, Bodily pain, and Vitality (energy and fatigue). Specific scoring details are provided in Taft et al. (2001).
Time frame: Baseline, month 3, month 6, month 9
Change in Mental Component Summary Score of SF-36
The RAND SF-36 mental component summary (MCS) score is a domain summary score that is part of the 36-Item Short Form Health Survey (SF-36). Scores range from 0 - 100. Higher scores indicating better mental health or function. The MCS score is calculated by adding up standardized, weighted scores based on eight domains of health, including physical functioning and pain: Limitations in physical activities due to health problems, Bodily pain, and Vitality (energy and fatigue). Specific scoring details are provided in Taft et al. (2001).
Time frame: Baseline, month 3, month 6, month 9
Participants were recruited through churches and organizations in several KY counties in Appalachian Kentucky
| Milestone | Diabetes Self-Management Program (DSMP) Only | Diabetes Self-Management Program (DSMP)Delayed | Tailored Patient Navigation (PN) Only | DSMP AND Tailored Patient Navigation |
|---|---|---|---|---|
| Started | 198 | 200 | 120 | 183 |
| Completed | 150 | 144 | 91 | 138 |
| Not completed | 48 | 56 | 29 | 45 |
| Withdrew: Withdrawal by subject | 36 | 29 | 11 | 27 |
| Withdrew: Covid | 0 | 23 | 0 | 0 |
| Withdrew: Participant moved from area | 1 | 0 | 0 | 0 |
| Withdrew: Lost to follow-up | 11 | 3 | 18 | 17 |
| Withdrew: Death | 0 | 1 | 0 | 0 |
| Withdrew: Participant removed | 0 | 0 | 0 | 1 |
Changes in hemoglobin A1c (HbA1c) will be measured with a Bayer DCA 2000+ Analyzer (21), which has a test coefficient of variation \< 5% consistent with requirements of the National Diabetes Data Group.
| percentage of glycated hemoglobin | Diabetes Self-Management Program (DSMP) Only | Diabetes Self-Management Program (DSMP) Delayed | Tailored Patient Navigation (PN) Only | DSMP AND Tailored Patient Navigation |
|---|---|---|---|---|
| baseline to month 3 | -0.37 ± 0.07 | -0.15 ± 0.08 | -0.31 ± 0.12 | -0.20 ± 0.10 |
| baseline to month 6 | -0.38 ± 0.08 | -0.37 ± 0.08 | -0.21 ± 0.14 | -0.20 ± 0.11 |
| baseline to month 9 | -0.40 ± 0.09 | -0.22 ± 0.10 | — | — |
Change in calculated as a change in weight in kilograms divided by the square of height in meter.
| kg/m2 | Diabetes Self-Management Program (DSMP) Only | Diabetes Self-Management Program (DSMP) Delayed | Tailored Patient Navigation (PN) Only | DSMP AND Tailored Patient Navigation |
|---|---|---|---|---|
| baseline to month 3 | -0.06 ± 0.10 | -0.23 ± 0.10 | -0.44 ± 0.13 | -0.14 ± 0.10 |
| baseline to month 6 | -0.05 ± 0.12 | -0.34 ± 0.13 | -0.57 ± 0.21 | -0.35 ± 0.17 |
| baseline to month 9 | -0.16 ± 0.14 | -0.41 ± 0.14 | — | — |
Change in Waist circumference at the umbilical waist using the Tech-Med model cat. no. 4414.
| inches | Diabetes Self-Management Program (DSMP) | Diabetes Self-Management Program (DSMP) Delayed | Tailored Patient Navigation (PN) Only | DSMP AND Tailored Patient Navigation |
|---|---|---|---|---|
| baseline to month 3 | -0.25 ± 0.16 | -0.41 ± 0.16 | -0.54 ± 0.22 | -0.46 ± 0.18 |
| baseline to month 6 | -0.63 ± 0.18 | -0.89 ± 0.18 | -0.63 ± 0.29 | -0.99 ± 0.23 |
| baseline to month 9 | -1.09 ± 0.19 | -0.73 ± 0.19 | — | — |
Number of participants with a primary care provider that attended a clinic visit with that provider within the last 3 months.
| Participants | Diabetes Self-Management Program (DSMP) Only | Diabetes Self-Management Program (DSMP)Delayed | Tailored Patient Navigation (PN) Only | DSMP AND Tailored Patient Navigation |
|---|---|---|---|---|
| PCP Visit in last 3 months at baseline | 113 | 118 | 70 | 87 |
| No Visit to PCP in last 3 months at baseline | 15 | 22 | 13 | 11 |
Change in systolic blood pressure will be reported as the average of two sphygmomanometer readings
| mm Hg | Diabetes Self-Management Program (DSMP) Only | Diabetes Self-Management Program (DSMP) Delayed | Tailored Patient Navigation (PN) Only | DSMP AND Tailored Patient Navigation |
|---|---|---|---|---|
| baseline to month 3 | -4.37 ± 1.56 | -0.47 ± 1.58 | -2.97 ± 1.95 | -3.86 ± 1.56 |
| baseline to month 6 | -4.22 ± 1.59 | 0.46 ± 1.63 | -6.60 ± 2.04 | -3.56 ± 1.66 |
| baseline to month 9 | -5.85 ± 1.75 | 1.02 ± 1.85 | — | — |
Change in diastolic blood pressure will be reported as the average of two sphygmomanometer readings
| mm Hg | Diabetes Self-Management Program (DSMP) Only | Diabetes Self-Management Program (DSMP) Delayed | Tailored Patient Navigation (PN) Only | DSMP AND Tailored Patient Navigation |
|---|---|---|---|---|
| baseline to month 3 | -2.25 ± 0.86 | -1.60 ± 0.87 | -3.01 ± 1.30 | -1.12 ± 1.04 |
| baseline to month 6 | -1.79 ± 0.87 | -1.69 ± 0.89 | -4.09 ± 1.33 | -1.07 ± 1.08 |
| baseline to month 9 | -2.95 ± 0.95 | -3.57 ± 1.01 | — | — |
blood will be drawn and HDL will be measured using a Cholestech LDX point of care machine. Data will be reported as the change in HDL over 18 months
No measurements were reported for this outcome.
blood will be drawn and LDL will be measured using a Cholestech LDX point of care machine. Data will be reported as the change in LDL over 18 months
No measurements were reported for this outcome.
blood will be drawn and Total cholesterol will be measured using a Cholestech LDX point of care machine. Data will be reported as the change in total cholesterol over 18 months
No measurements were reported for this outcome.
The RAND SF-36 physical component summary (PCS) score is a domain summary score that is part of the 36-Item Short Form Health Survey (SF-36). Scores range from 0 - 100. Higher scores indicate better health or function. The PCS score is calculated by adding up standardized, weighted scores based on eight domains of health, including physical functioning and pain: Limitations in physical activities due to health problems, Bodily pain, and Vitality (energy and fatigue). Specific scoring details are provided in Taft et al. (2001).
| score on a scale | Diabetes Self-Management Program (DSMP) Only | Diabetes Self-Management Program (DSMP) Delayed | Tailored Patient Navigation (PN) Only | DSMP AND Tailored Patient Navigation |
|---|---|---|---|---|
| baseline to month 3 | 0.29 ± 0.64 | -0.74 ± 0.67 | -1.39 ± 0.89 | 1.00 ± 0.70 |
| baseline to month 6 | 1.00 ± 0.69 | -0.40 ± 0.71 | 0.92 ± 0.93 | 1.05 ± 0.75 |
| baseline to month 9 | 0.28 ± 0.74 | -1.05 ± 0.79 | — | — |
The RAND SF-36 mental component summary (MCS) score is a domain summary score that is part of the 36-Item Short Form Health Survey (SF-36). Scores range from 0 - 100. Higher scores indicating better mental health or function. The MCS score is calculated by adding up standardized, weighted scores based on eight domains of health, including physical functioning and pain: Limitations in physical activities due to health problems, Bodily pain, and Vitality (energy and fatigue). Specific scoring details are provided in Taft et al. (2001).
| score on a scale | Diabetes Self-Management Program (DSMP) Only | Diabetes Self-Management Program (DSMP) Delayed | Tailored Patient Navigation (PN) Only | DSMP AND Tailored Patient Navigation |
|---|---|---|---|---|
| baseline to month 3 | 1.67 ± 0.74 | 1.73 ± 0.77 | 4.24 ± 1.03 | 1.21 ± 0.81 |
| baseline to month 6 | 1.56 ± 0.83 | 1.66 ± 0.85 | 4.05 ± 1.10 | 0.92 ± 0.89 |
| baseline to month 9 | 2.67 ± 0.84 | 1.82 ± 0.89 | — | — |
Collected over 9 months. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Diabetes Self-Management Program (DSMP) Only | 0/198 (0%) | 0/198 (0%) | 0/198 (0%) |
| Diabetes Self-Management Program (DSMP) Delayed | 1/200 (0.5%) | 0/200 (0%) | 0/200 (0%) |
| Tailored Patient Navigation (PN) Only | 0/120 (0%) | 0/120 (0%) | 0/120 (0%) |
| DSMP AND Tailored Patient Navigation | 0/183 (0%) | 0/183 (0%) | 0/183 (0%) |
| Age, Continuous(years) | Diabetes Self-Management Program (DSMP) Only | Diabetes Self-Management Program (DSMP) Delayed | Tailored Patient Navigation (PN) Only | DSMP AND Tailored Patient Navigation | Total |
|---|---|---|---|---|---|
| Mean | 63.0 ± 11.6 | 65.3 ± 9.3 | 61.9 ± 13.3 | 62.7 ± 11.2 | 63.4 ± 11.3 |
| Sex: Female, Male(Participants) | Diabetes Self-Management Program (DSMP) Only | Diabetes Self-Management Program (DSMP) Delayed | Tailored Patient Navigation (PN) Only | DSMP AND Tailored Patient Navigation | Total |
|---|---|---|---|---|---|
| Female | 136 | 121 | 76 | 116 | 449 |
| Male | 62 | 79 | 44 | 67 | 252 |
| Ethnicity (NIH/OMB)(Participants) | Diabetes Self-Management Program (DSMP) Only | Diabetes Self-Management Program (DSMP) Delayed | Tailored Patient Navigation (PN) Only | DSMP AND Tailored Patient Navigation | Total |
|---|---|---|---|---|---|
| Hispanic or Latino | 1 | 1 | 1 | 1 | 4 |
| Not Hispanic or Latino | 197 | 199 | 119 | 182 | 697 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Diabetes Self-Management Program (DSMP) Only | Diabetes Self-Management Program (DSMP) Delayed | Tailored Patient Navigation (PN) Only | DSMP AND Tailored Patient Navigation | Total |
|---|---|---|---|---|---|
| American Indian or Alaska Native | 1 | 1 | 0 | 4 | 6 |
| Asian | 0 | 0 | 1 | 0 | 1 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 | 0 | 0 |
| Black or African American | 8 | 1 | 11 | 4 | 24 |
| White | 189 | 198 | 107 | 175 | 669 |
| More than one race | 0 | 0 | 1 | 0 | 1 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 0 |
| Region of Enrollment(participants) | Diabetes Self-Management Program (DSMP) Only | Diabetes Self-Management Program (DSMP) Delayed | Tailored Patient Navigation (PN) Only | DSMP AND Tailored Patient Navigation | Total |
|---|---|---|---|---|---|
| United States | 198 | 200 | 120 | 183 | 701 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Apr 2018 to primary completion in Jul 2023, 62 months.
Results were first posted in Aug 2024, 1 year 1 month after primary completion.
Of 1,590 non-industry interventional studies with no phase under Diabetes Mellitus, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 62 months is above that.
Counting every sponsor, half of 1,750 studies reached it within 21 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nancy Schoenberg